Spero Therapeutics, Inc. (SPRO)
2.515
-0.04
(-1.37%)
USD |
NASDAQ |
Jan 12, 16:00
2.515
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Research and Development Expense (Quarterly): 8.597M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 188.52M |
| Amicus Therapeutics, Inc. | 23.42M |
| Cassava Sciences, Inc. | 3.955M |
| Omeros Corp. | 15.76M |
| GeoVax Labs, Inc. | 5.044M |